Machine Learning

Neurizon Therapeutics has started dosing its promising ALS drug, NUZ-001, in the groundbreaking HEALEY Platform Trial, a pivotal step for patients.

Facing user burnout and fierce rivals, Tinder's first-ever product event aims to reignite the flame. Can new tech and a new vision save the dating giant?

A new study shows alternating magnetic fields can destroy antibiotic-resistant biofilms on medical implants, offering hope for a non-surgical treatment.

With TGA approval, Optellum's AI platform arrives to help tackle Australia's low lung cancer survival rates by enabling earlier, more accurate detection.

With Phase 3 epilepsy results for its lead drug azetukalner due in March, Xenon reveals a major R&D spend and a cash runway to fuel its broad pipeline.

Unox's new North Carolina plant promises faster service, but it enters a hot market where 'Made in USA' rivals are already well-established.

New software from OBM automates energy use for Bitcoin miners and data centers, turning them from grid burdens into flexible, profitable grid assets.

Amid new regulations, eClinical Solutions unveils agentic AI to automate data review, streamline compliance, and accelerate breakthrough therapies.

Biotech giant Regeneron extends its sponsorship of America's top high school science contest, securing its legacy and boosting access for a new generation.

As robots and drones move from labs to reality, Encord's new funding highlights the critical role of data infrastructure in powering the physical AI revolution.

BLUETTI's new Elite 300 packs 3kWh of power into a surprisingly small frame, aiming to be the go-to for storm prep and off-grid travel.

The deal merges Fractional AI's enterprise scale with Fabius's workflow automation, highlighting a trend of consolidation in the applied AI sector.

A new report reveals record renewable growth is causing grid saturation and price volatility, pushing AI and battery storage to the forefront of the solution.

Jacobi Strategies unveils a new AI-assisted coding platform, enabling investment firms to build bespoke applications in a secure, private environment.

With $13M in new funding, BrainCheck is expanding its AI platform to help doctors detect dementia earlier and manage cognitive care at scale.

As Acorn preps its Q4 results, we look at the microcap's macro impact on grid reliability, cell towers, and the burgeoning smart energy market.

GEMMABio has dosed the first infant in a trial for its next-gen SMA1 gene therapy, a new approach designed to improve safety and global access.

As AI assistants reshape search, many top brands are invisible. A new AI Authority Index aims to fix this 'clarity problem' before it's too late.

Luna Federici, the architect of PicnicHealth's recent growth, takes the helm as President to scale the company's patient-first, AI-powered research model.

In its debut, Identy.io achieves top-tier NIST results, challenging industry giants with superior speed and accuracy for border and national security.